Bacteremia clinical trials

Explore recruiting bacteremia clinical trials.

Recruiting bacteremia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bacteremia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PETERPEN)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

PK/PD of Cefadroxil in Staphylococcus Aureus Bacteremia, a preliminary study

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multi-Center, Randomized, Single-Blind Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complicated Urinary Tract Infection, Acute Uncomplicated Pyelonephritis, Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia, and Complicated Intra-Abdominal Infection due to Carbapenem Resistant Enterobacterales (OP0595-6)

France, Czechia, Greece, Slovakia, Latvia, Croatia +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Netherlands, Germany, Sweden, France

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Bacteremia trials by city

Bacteremia in Toronto Bacteremia in Vancouver Bacteremia in Montreal Bacteremia in Calgary Bacteremia in Edmonton Bacteremia in Ottawa Bacteremia in Winnipeg Bacteremia in Quebec City Bacteremia in Hamilton Bacteremia in Kitchener Bacteremia in London Bacteremia in Halifax Bacteremia in New York Bacteremia in Los Angeles Bacteremia in Chicago Bacteremia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease